IAIM
GENE

International Assets Investment Management’s Genetic Technologies Ltd. GENE Stock Holding History

International Assets Investment Management’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-140
Closed -$3K – 2019
2021
Q1 		$3K Hold
140
– – ﹤0.01% 1966
2020
Q4 		$3K Buy
+140
New +$2.31K ﹤0.01% 1845

Other funds holding GENE

Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $5.32B AUM 30.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

International Assets Investment Management's GENE Position: Q2 2021 in Review

International Assets Investment Management sold out of Genetic Technologies Ltd. (GENE) in Q2 2021, closing a stake of 140 shares — an estimated $3K sold.

International Assets Investment Management first reported a position in GENE in Q4 2020 and held it in 2 quarters. The position peaked at $3K in Q1 2021. 15 funds tracked by Wall St. Rank hold GENE as of Q2 2021.

  • International Assets Investment Management reported no remaining Genetic Technologies Ltd. position as of Q2 2021 after selling out during the quarter.
  • International Assets Investment Management sold 140 Genetic Technologies Ltd. shares in Q2 2021, an estimated $3K.
  • International Assets Investment Management first reported a position in Genetic Technologies Ltd. in Q4 2020 and held it in 2 quarters.
  • International Assets Investment Management's Genetic Technologies Ltd. position peaked at $3K in Q1 2021.
  • 15 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.